US5147661046 - Common Stock
LIFECORE BIOMEDICAL INC
NASDAQ:LFCR (12/20/2024, 8:22:07 PM)
After market: 7.2393 0 (-0.01%)7.24
+0.17 (+2.4%)
Lifecore Biomedical, Inc. is a contract development and manufacturing organization, which engages in the provision of differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. The company is headquartered in Chaska, Minnesota and currently employs 524 full-time employees. The firm designs, develops, manufactures and sells differentiated products for biomaterials markets and license technology applications to partners. The firm offers highly differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. The company is involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a spectrum of medical conditions and procedures. The firm uses its fermentation process and aseptic formulation and filling expertise to develop HA-based products for multiple applications and to take advantage of non-HA devices and drug opportunities.
LIFECORE BIOMEDICAL INC
3515 Lyman Boulevard
Chaska MINNESOTA
P: 19523684300
Employees: 524
Website: https://www.lifecore.com/
Webcast Scheduled for Thursday, January 2 at 4:30 p.m. Eastern
Webcast Scheduled for Thursday, January 2 at 4:30 p.m. Eastern...
Development Services Span Tech Transfer, Process Assessment and Method Validation for Fill and Finish of NRS-033 for Planned Phase 2 Trial Lifecore to...
Three-Year Term Extension Combined with Simplification and Reduction of Interest Rates Helps Further Strengthen Company’s Balance Sheet and Overall...
Here you can normally see the latest stock twits on LFCR, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: